Skip to content
Home/Companies/HealthTech/Diaceutics
Diaceutics

Diaceutics

HealthTech·UK·Exited 2019·Held 4yr
Entry
2015
Hold
4yr
Exit
2019

Who owns Diaceutics?

Diaceutics was owned by Clarendon Fund Managers through Co-Fund NI (2012 vintage) from 2015 to 2019, exited via IPO.

Hand-verified · updated 2026-07-08

Clarendon Fund Managers
Investor
Clarendon Fund Managers
Co-Fund NI · 2012 · VC

Key facts

HQUnited Kingdom
SectorHealthTech
StatusAcquired
Websitewww.diaceutics.com
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019

More from Co-Fund NI

Other portfolio companies in the same fund.

GenoME Diagnostics
GenoME Diagnostics
Active
BiotechUK· 2023
Kinsetsu
Active
SaaSUK· 2023
Amply
Amply
Active
BiotechUK· 2022
Angoka
Angoka
Active
CybersecurityUK· 2022
Aramune Technologies
Aramune Technologies
Active
BiotechUK· 2022
CV6 Therapeutics
CV6 Therapeutics
Active
BiotechUK· 2022

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Diaceutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Diaceutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Diaceutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue